American Regent, Inc.
Clinical trials sponsored by American Regent, Inc., explained in plain language.
-
New drug injection tested for Tough-to-Treat skin cancer
Disease control CompletedThis study tested a weekly injection called Taxoprexin in 30 patients with advanced skin melanoma that had spread to other parts of the body. The goal was to see if the treatment could shrink tumors, control the disease, and extend survival. Patients received the injections weekl…
Phase: PHASE2 • Sponsor: American Regent, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New drug tested for rare, spreading eye cancer
Disease control CompletedThis study tested a weekly chemotherapy drug called Taxoprexin in patients whose eye melanoma had spread to other parts of the body. The main goal was to see if the drug could shrink tumors and how long patients lived. It involved 22 participants who received the drug by IV infus…
Phase: PHASE2 • Sponsor: American Regent, Inc. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC